Compositions and methods for therapeutic delivery with frozen particles
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
G06F-019/00
A61M-005/30
A61K-009/14
A61M-005/00
출원번호
US-0290691
(2008-10-31)
등록번호
US-8731841
(2014-05-20)
발명자
/ 주소
Boyden, Edward S.
Hyde, Roderick A.
Leuthardt, Eric C.
Myhrvold, Nathan P.
Sweeney, Elizabeth A.
Wood, Jr., Lowell L.
출원인 / 주소
The Invention Science Fund I, LLC
인용정보
피인용 횟수 :
0인용 특허 :
171
초록▼
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particula
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.
대표청구항▼
1. A system comprising: at least one computing device;at least one computer program, configured with a computer-readable medium, for use with at least one computer system and wherein the computer program includes a plurality of instructions that when executed on the computing device cause the comput
1. A system comprising: at least one computing device;at least one computer program, configured with a computer-readable medium, for use with at least one computer system and wherein the computer program includes a plurality of instructions that when executed on the computing device cause the computing device to direct a pre-determined patterned delivery of a plurality of frozen particle therapeutic compositions to at least one biological tissue of at least one subject by a remote controlled device, the plurality of frozen particle therapeutic compositions including at least two sub-sets of frozen particles that include different therapeutic agents and at least one tracer agent; and compare information related to the delivery with information regarding at least one clinical outcome following receipt by the at least one subject; andat least one imaging device configured to measure the at least one tracer agent and provide real-time feedback control of the plurality of frozen particle therapeutic compositions administered to the at least one subject. 2. The system of claim 1, wherein the information related to the delivery includes information regarding amount of the plurality of therapeutic compositions or identity of at least one therapeutic agent administered to at least one biological tissue of at least one subject. 3. The system of claim 1, wherein the information related to the delivery includes information regarding at least one dimension of biological tissue penetration. 4. The system of claim 3, wherein the information regarding at least one dimension of biological tissue penetration includes information regarding at least one of depth, width, or breadth of administration of the plurality of frozen particle therapeutic compositions to at least one biological tissue of at least one subject. 5. The system of claim 1, wherein the computing device is configured to communicate with at least one printing device, at least one imaging device, or at least one input device. 6. The system of claim 1, wherein the information related to delivery includes information regarding two or more subjects with one or more common attributes. 7. The system of claim 1, wherein the information related to delivery includes information regarding at least one cellular or tissue source. 8. The system of claim 7, wherein the information regarding at least one cellular or tissue source includes information regarding at least one abnormal cellular or tissue source. 9. The system of claim 7, wherein information regarding the at least one cellular or tissue source includes information regarding at least one type of cell or tissue. 10. The system of claim 1, wherein at least one frozen particle therapeutic composition of the plurality includes at least one of nitrogen, carbon dioxide, hydrogen oxide, helium, neon, xenon, krypton, air, oxygen, chlorine, oxygen, air, bromine, argon, polyethylene glycol, acetone, ethyl acetate, dimethyl sulfoxide, dimethyl formamide, dioxane, hexamethylphosphorotriamide, perfluorohydrocarbon, methanol, ethanol, tert-butyl alcohol, formic acid, hydrogen fluoride, ammonia, acetic acid, benzene, carbon tetrachloride, acetonitrile, hexane, methylene chloride, carboxylic acid, saline, Ringer's solution, lactated Ringer's solution, Hartmann's solution, acetated Ringer's solution, phosphate buffered solution, TRIS-buffered saline solution, Hank's balanced salt solution, Earle's balanced salt solution, standard saline citrate, HEPES-buffered saline, dextrose, glucose, or diethyl ether. 11. The system of claim 1, wherein the frozen particles of the plurality have at least one major dimension of approximately one centimeter or less, approximately one millimeter or less, approximately one micrometer or less, approximately one nanometer or less, or any value therebetween. 12. The system of claim 1, wherein at least one sub-set of the plurality of frozen particle therapeutic compositions includes one or more reinforcement agents. 13. The system of claim 1, wherein the at least one frozen particle therapeutic composition includes one or more explosive materials. 14. The system of claim 1, wherein the receipt by the at least one subject of at least one frozen particle therapeutic composition is pursuant to at least one clinical trial. 15. The system of claim 1, further including determining at least one correlation before the administration of the plurality of frozen particle therapeutic compositions. 16. The system of claim 1, further including creating at least one inclusion criterion and at least one exclusion criterion for a clinical trial involving the delivery of the plurality of frozen particle therapeutic compositions. 17. The system of claim 1, further including suggesting the inclusion of one or more of the at least one subject in at least one clinical trial. 18. The system of claim 1, further including suggesting the exclusion of one or more of the at least one subject in at least one clinical trial. 19. The system of claim 1, further including using one or more of the at least one comparison to predict at least one clinical outcome regarding at least one second subject. 20. The system of claim 19, wherein the at least one second subject has not received the plurality of frozen particle therapeutic compositions. 21. The system of claim 19, wherein using one or more of the at least one comparison further includes predicting at least one clinical outcome involving the at least one second subject, wherein the at least one second subject is a plurality of people; and segregating subject identifiers associated with the plurality of people in reference to the predicted at least one clinical outcome. 22. The system of claim 19, wherein using one or more of the at least one comparison includes the at least one second subject is a plurality of people; and determining the eligibility of the at least one second subject for the at least one clinical trial. 23. A system, comprising: at least one computing device;at least one computer program, configured with a computer-readable medium, for use with at least one computer system and wherein the computer program includes a plurality of instructions that when executed on the computing device cause the computing device to direct a pre-determined patterned delivery of a plurality of frozen particle therapeutic compositions to at least one biological tissue of at least one subject by a remote controlled device, the plurality of frozen particle therapeutic compositions including at least two sub-sets of frozen particles that include different therapeutic agents and at least one tracer agent, and compare information related to the delivery, and information regarding the plurality of frozen particle therapeutic compositions;one or more instructions for applying one or more comparisons to the information related to the delivery to a plurality of people;detect the at least one tracer agent, andprovide real-time feedback control of the amount of the plurality of frozen particle therapeutic compositions administered to the at least one subject. 24. The system of claim 23, further including one or more instructions for segregating subject identifiers associated with the plurality of people in reference to at least one of the one or more applied comparisons. 25. The system of claim 23, wherein the information related to the delivery includes information regarding the amount of therapeutic composition or therapeutic agent administered to at least one biological tissue of at least one subject. 26. The system of claim 23, wherein the information related to the delivery includes information regarding at least one dimension of biological tissue penetration. 27. The system of claim 26, wherein the information regarding at least one dimension of biological tissue penetration includes information relating to at least one of depth, width, or breadth of administration by a pellet gun of the at least one frozen particle therapeutic composition to at least one biological tissue of at least one subject. 28. The system of claim 23, further including one or more instructions for segregating individual identifiers associated with the plurality of people in reference to at least one characteristic shared by two or more subjects in the plurality of people. 29. A system, comprising: at least one computing device;at least one computer program, configured with a computer-readable medium, for use with at least one computer system and wherein the computer program includes a plurality of instructions that when executed on the at least one computing device cause the computing device to direct a pre-determined patterned delivery of a plurality of frozen particle therapeutic compositions to at least one biological tissue of at least one subject by a remote controlled device, the plurality of frozen particle therapeutic compositions including at least two sub-sets of frozen particles that include different therapeutic agents and at least one tracer agent; and compare information relating to delivery, and information regarding at least one frozen particle therapeutic composition of the plurality;one or more instructions for applying one or more comparisons to the information related to delivery to a plurality of people;one or more instructions for determining from the comparison at least one biological change following administration of one or more frozen particle therapeutic compositions of the plurality to the subject; andat least one imaging device configured to measure the at least one tracer agent and provide real-time feedback control of the amount of the at least one frozen particle therapeutic composition administered to the at least one subject. 30. The system of claim 1, wherein the tracer agent includes at least one of an electronic identification device, radioactive element, luminescent substance, fluorescent substance, phosphorescent substance, quantum dot, or magnetic particle.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (171)
Phillips William T. (San Antonio TX) Klipper Robert W. (San Antonio TX) Timmons James H. (Tacoma WA) Rudolph Alan S. (Bowie MD), 99m TC labeled liposomes.
Smits Georges (Gijzegem-Aalst BEX) Daenekindt Luc (Gijzegem-Aalst BEX) Booten Karl (Geetbets BEX), Agglomerated composition, process for producing it and food products containing the said composition.
Kleiner Fredric (New City NY) Roy PradipK. (Yorktown NY), Apparatus and process for the preparation of gasified confectionaries by pressurized deposit molding.
Opel Alan E. (Monrovia CA) Spivak Philip (Toluca Lake CA) Zadorozhny Oleg (North Hollywood CA), Apparatus for producing and blasting sublimable granules on demand.
Armstrong Jay (1543 Weymouth Cir. ; Apt. 109 Westlake OH 44145) Becker James R. (6272 Mills Creek La. North Ridgeville OH 44039), Blast cleaning system.
Topalian Harry H. (Dover DE) Wyss Clement R. (Lewes DE) Kenyon Ralph E. (Dover DE) Dec Anthony F. (Dover DE), Frozen aerated ready-to-eat gelatin composition.
Kitamura Hiroshi (Shizuoka JPX) Mitsuuchi Masamichi (Shizuoka JPX), Glass-reinforced thermoplastic resin compositions containing the anatase form of titanium dioxide as a white pigmenting.
Brinegar Chris (587 Locksley Rd. Boulder Creek CA 95006) Gilmore James (6385 Camino Verde Dr. San Jose CA 95119) Johnson Michael (6385 Camino Verde Dr. San Jose CA 95119) Walker Nigel (5385 Broadway , Ice-mediated introduction of substances into biological material.
Thomas Dag Horn ; Sandra Marchese Johnson, Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction.
Rahman Aquilur (Gaithersburg MD) Rafaeloff Rafael (Tel-Aviv MD ILX) Husain Syed R. (Gaithersburg MD), Liposome encapsulated taxol and a method of using the same.
Weaver, James C.; Anderson, R. Rox; Herndon, Terry O; Gowrishankar, T. R.; Gift, Elizabeth A.; Gonzalez, Salvador, Localized molecular and ionic transport to and from tissues.
Poulsen, Jens Ulrik; Christensen, Lars Hofmann; Aasmul, S.o slashed.ren, Method and a system for assisting a user in a medical self treatment, said self treatment comprising a plurality of actions.
Power Wendy ; Reed Michael A. ; Frustaci Dominick J. ; Larocque Gerald ; Marchetti Brenda, Method and apparatus for determining quantity of liquid in a container and/or lack of motion thereof.
Westergaard Knud E. (Rolighedsvej 16 9560 Hadsund DKX), Method and apparatus for particle blasting using particles of a material that changes its state.
Frohlich, Hans; Gebhardt, Sabine; Trampusch, Berthold, Method and device for generating a two-phase gas-particle jet, in particular containing CO2 dry ice particles.
Cates Michael C. (Solana Beach CA) Hamm Richard R. (San Diego CA) Lewis Michael W. (Wichita KS) Schmitz Wayne N. (St. Louis MO), Method and system for removing a coating from a substrate using radiant energy and a particle stream.
Sanford John C. (Geneva NY) Wolf Edward D. (Ithaca NY) Allen Nelson K. (Newfield NY), Method for transporting substances into living cells and tissues and apparatus therefor.
Bellhouse Brian J. (Islip GB2) Sarphie David F. (Witney GB2) Greenford John C. (Abingdon GB2), Method of delivering powder transdermally with needless injector.
Costantino Henry R. ; Jaworowicz Warren E. ; Tracy Mark A. ; Beganski Christopher P., Method of producing sub-micron particles of biologically active agents and uses thereof.
Cummins Thomas J. (Rochester NY) Ekeze Tobias D. (Rochester NY), Methods of extracting nucleic acids and PCR amplification without using a proteolytic enzyme.
Rhim Won-Kyu (Pasadena CA) Hyson Michael T. (Glendale CA) Chung Sang-Kun (Diamond Bar CA) Colvin Michael S. (Malibu CA) Chang Manchium (Los Angeles CA), Monodisperse, polymeric microspheres produced by irradiation of slowly thawing frozen drops.
Shih, Hong; Leonte, Oana M.; Daugherty, John E.; Huang, Tuochuan; Goldspring, Gregory J.; May, Michael C., On-line chamber cleaning using dry ice blasting.
Clark ; Jr. William G. (Murrysville PA) Herald John J. (Monroeville PA) Liaw Peter K. (Knoxville TN), Pressurized ferrofluid paint removal system using an electromagnet and eddy current encircling coil to adjust weight per.
Fages Jacques,FRX ; Marty Alain,FRX ; Combes Didier,FRX ; Condoret Jean-Stephane,FRX, Process for treating bone tissue and corresponding implantable biomaterials.
Clauss Steven L. (Manville NJ) Pastel Michael J. (Highland Mills NY) Zawadzki Rainer K. (Wuhan CNX), Stable porfimer sodium compositions and methods for their manufacture.
Boyden, Edward S.; Cook, Daniel B.; Hyde, Roderick A.; Leuthardt, Eric C.; Myhrvold, Nathan P.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L., Systems, devices, and methods for making or administering frozen particles.
Santa Cruz Cathy D. ; Deniston-Korgol Christine L. ; Baugh Barbara I. ; Baugh Alexandria D. ; Baugh Roger D., Weather-proof wrist, forearm, and elbow protectors.
Dean ; Jr. Robert C. (Norwich VT) Silver Frederick H. (Long Valley NJ) Berg Richard A. (Lambertville NJ) Phillips Philip G. (Norwich VT) Runstadler ; Jr. Peter W. (Hanover NH), Weighted collagen microsponge for immobilizing bioactive material.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.